Latest news with #JTCTeam
Miami Herald
08-05-2025
- Business
- Miami Herald
JTC Team Hosts Virtual Investor 'KOL Connect' Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level
Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN, NJ / ACCESS Newswire / May 8, 2025 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "KOL Connect" segment featuring Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Key Opining Leader (KOL), Louis J. Aronne, MD, FACP. Veru Inc. (NASDAQ:VERU) is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company's drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease. As part of this "KOL Connect" segment, Dr. Steiner and Dr. Aronne discussed obesity and GLP-1s, the current treatment landscape and areas of unmet need, highlighting Veru's lead program, the enobosarm QUALITY Phase 2b study, and the clinical data released by Veru to date. The Virtual Investor "KOL Connect" segment featuring Veru Inc. is now available here. To access all Virtual Investor Events, visit About JTC TeamJTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn. CONTACTJenene ThomasJTC Team, LLCT: +1 (908) 824-0775jtc@ SOURCE: JTC Team, LLC
Associated Press
08-05-2025
- Business
- Associated Press
JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level
Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the 'KOL Connect' segment here FRENCHTOWN, NJ / ACCESS Newswire / May 8, 2025 / JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor 'KOL Connect' segment featuring Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Key Opining Leader (KOL), Louis J. Aronne, MD, FACP. Veru Inc. (NASDAQ:VERU) is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company's drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease. As part of this 'KOL Connect' segment, Dr. Steiner and Dr. Aronne discussed obesity and GLP-1s, the current treatment landscape and areas of unmet need, highlighting Veru's lead program, the enobosarm QUALITY Phase 2b study, and the clinical data released by Veru to date. The Virtual Investor 'KOL Connect' segment featuring Veru Inc. is now available here. To access all Virtual Investor Events, visit About JTC Team JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn. CONTACT Jenene Thomas JTC Team, LLC T: +1 (908) 824-0775 [email protected] SOURCE: JTC Team, LLC press release
Miami Herald
19-02-2025
- Business
- Miami Herald
Virtual Investor 'Top 5 for '25' Conference Hosted by JTC Now Available On-Demand
- Access video webcasts from the first wave of participating companies here FRENCHTOWN, NJ / ACCESS Newswire / February 19, 2025 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the Virtual Investor "Top 5 for '25" Conference is now available on-demand. For the event, management from the participating companies provided their top five reasons of why they believe the investment community and industry colleagues should pay attention to their company in 2025. The first wave of participating companies includes: Akari Therapeutics, Plc (NASDAQ:AKTX) - WebcastAutonomix Medical, Inc. (NASDAQ:AMIX) - WebcastAmerican Resources Corporation (NASDAQ:AREC) - WebcastCNS Pharmaceuticals, Inc. (NASDAQ:CNSP) - WebcastenVVeno Medical Corporation (NASDAQ:NVNO) - WebcastExxel Pharma (Private) - WebcastGRI Bio, Inc. (NASDAQ:GRI) - WebcastKaida BioPharma (Private) -WebcastOutlook Therapeutics, Inc. (NASDAQ:OTLK) - WebcastPalisade Bio, Inc. (NASDAQ:PALI) - WebcastTuHURA Biosciences, Inc. (NASDAQ:HURA) - Webcast Additional companies are expected to participate in the Virtual Investor "Top 5 for '25" On-Demand Conference. JTC will announce the second wave of its participating companies once available on demand. All investors and interested parties can access the on-demand presentations on the Virtual Investor website, as well as the Investor sections of the respective company websites. JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies' websites and the SEC website for the latest information and filings on each company. About JTC TeamJTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn. CONTACTJenene ThomasJTC Team, LLCT: +1 (908) 824-0775jtc@ SOURCE: JTC Team, LLC
Associated Press
14-02-2025
- Business
- Associated Press
JTC Team to Host the Virtual Investor 'Top 5 for '25" On-Demand Conference
- Video webcasts to be available on-demand Wednesday, February 19th - Participating company line-up to be announced - Top 5 for '25 promo video can be accessed here FRENCHTOWN, NJ / ACCESS Newswire JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor 'Top 5 for '25" Conference with on-demand presentations available beginning Wednesday, February 19, 2025. For the event, management from the participating companies will provide their top five reasons of why they believe the investment community and industry colleagues should pay attention to their company in 2025. All investors and interested parties will be able to access the list of participating companies at The on-demand presentations will be available on the Virtual Investor website, as well as the Investor sections of the respective company websites. To access all Virtual Investor events, visit JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies' websites and the SEC website for the latest information and filings on each company. About JTC Team JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn. Contact: Jenene Thomas JTC Team, LLC
